On October 23, 2015 the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) issued a policy regarding the use of serogroup B meningococcal (MenB) vaccine.  It indicates that a MenB vaccine may be administered to adolescents aged 16-23 to provide short term protection against most strains of serogroup B meningococcal disease.  

The complete report can be found here:


We do not carry the MenB vaccines (most commonly Bexsero or Trumenba). 

However, several pharmacies close to campus have it available, or can order it.  Importantly, these vaccines are billed as a prescription, and insurance coverage varies significantly by plan.  Please contact your insurance provider for more information regarding coverage.

Centers for Disease Control and Prevention Information on Meningitis


The most recent Meningitis Vaccine Information Statement from the CDC can be found here:   


Willamette University

Health Services

Baxter Hall
900 State Street
Salem Oregon 97301 U.S.A.
503-370-6062 voice
503-375-5420 fax

Back to Top